Y. Yarden and M. X. Sliwkowski, Untangling the ErbB signalling network, Nat. Rev. Mol. Cell Biol, vol.2, pp.127-137, 2001.

S. A. Ettenberg, A. Magnifico, M. Cuello, M. M. Nau, Y. R. Rubinstein et al., Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex, J. Biol. Chem, vol.276, pp.27677-27684, 2001.

C. A. Joazeiro, S. S. Wing, H. Huang, J. D. Leverson, T. Hunter et al., The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase, Science, vol.286, pp.309-312, 1999.

G. Levkowitz, H. Waterman, S. A. Ettenberg, M. Katz, A. Y. Tsygankov et al., Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1, Mol. Cell, vol.4, pp.1029-1040, 1999.

C. B. Thien and W. Y. Langdon, Cbl: many adaptations to regulate protein tyrosine kinases, Nat. Rev. Mol. Cell Biol, vol.2, pp.294-307, 2001.

K. Haglund, S. Sigismund, S. Polo, I. Szymkiewicz, P. P. Di-fiore et al., Multiple monoubiquitination of RTKs is sufficient for their endocytosis and degradation, Nat. Cell Biol, vol.5, pp.461-466, 2003.

S. V. Sharma, D. W. Bell, J. Settleman, and D. A. Haber, Epidermal growth factor receptor mutations in lung cancer, Nat. Rev. Cancer, vol.7, pp.169-181, 2007.

K. Shtiegman, B. S. Kochupurakkal, Y. Zwang, G. Pines, A. Starr et al., Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling, Oncogene, vol.26, pp.6968-6978, 2007.

D. E. Quelle, F. Zindy, R. A. Ashmun, and C. J. Sherr, Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest, Cell, vol.83, pp.993-1000, 1995.

P. Ozenne, B. Eymin, E. Brambilla, and S. Gazzeri, The ARF tumor suppressor: structure, functions and status in cancer, Int J. Cancer, vol.127, pp.2239-2247, 2010.

L. B. Maggi, C. L. Winkeler, A. P. Miceli, A. J. Apicelli, S. N. Brady et al., ARF tumor suppression in the nucleolus, Biochim Biophys. Acta, pp.831-839, 1842.

B. Eymin, C. Leduc, J. L. Coll, E. Brambilla, and S. Gazzeri, p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice, Oncogene, vol.22, pp.1822-1835, 2003.

M. Mounawar, A. Mukeria, F. L. Calvez, R. J. Hung, H. Renard et al., Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history, Cancer Res, vol.67, pp.5667-5672, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00173094

A. B. Cortot, M. Younes, G. Martel-planche, B. Guibert, S. Isaac et al., Mutation of TP53 and alteration ofp14(arf) expression in EGFR-and KRAS-mutated lung adenocarcinomas, Clin. Lung Cancer, vol.15, pp.124-130, 2014.

P. Ozenne, D. Dayde, E. Brambilla, B. Eymin, and S. Gazzeri, P14(ARF) inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway, Oncogene, vol.32, pp.1050-1058, 2013.

D. Dayde, M. Guerard, P. Perron, A. S. Hatat, C. Barrial et al., Nuclear trafficking of EGFR by Vps34 represses Arf expression to promote lung tumor cell survival, Oncogene, vol.35, pp.3986-3994, 2016.

A. A. De-melker, G. Van-der-horst, J. Calafat, H. Jansen, and J. Borst, c-Cbl ubiquitinates the EGF receptor at the plasma membrane and remains receptor associated throughout the endocytic route, J. Cell Sci, vol.114, pp.2167-2178, 2001.

E. E. Er, M. C. Mendoza, A. M. Mackey, L. E. Rameh, and J. Blenis, AKT facilitates EGFR trafficking and degradation by phosphorylating and activating PIKfyve, Sci. Signal, vol.6, p.45, 2013.

P. Ray, Y. S. Tan, V. Somnay, R. Mehta, M. Sitto et al., Differential protein stability of EGFR mutants determines responsiveness to tyrosine kinase inhibitors, Oncotarget, vol.7, pp.68597-68613, 2016.

H. Kawagishi, H. Nakamura, M. Maruyama, S. Mizutani, K. Sugimoto et al., ARF suppresses tumor angiogenesis through translational control of VEGFA mRNA, Cancer Res, vol.70, pp.4749-4758, 2010.

M. J. Kuchenreuther and J. D. Weber, The ARF tumor-suppressor controls Drosha translation to prevent Ras-driven transformation, Oncogene, vol.33, pp.300-307, 2014.

M. R. Frey, R. S. Dise, K. L. Edelblum, and D. B. Polk, p38 kinase regulates epidermal growth factor receptor downregulation and cellular migration, EMBO J, vol.25, pp.5683-5692, 2006.

Y. Zheng, Y. D. Zhao, M. Gibbons, T. Abramova, P. Y. Chu et al., Tgfbeta signaling directly induces Arf promoter remodeling by a mechanism involving Smads 2/3 and p38 MAPK, J. Biol. Chem, vol.285, pp.35654-35664, 2010.

D. V. Bulavin, C. Phillips, B. Nannenga, O. Timofeev, L. A. Donehower et al., Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway, Nat. Genet, vol.36, pp.343-350, 2004.

S. Gazzeri, V. D. Valle, L. Chaussade, C. Brambilla, C. J. Larsen et al., The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer, Cancer Res, vol.58, pp.3926-3931, 1998.

S. Vonlanthen, J. Heighway, M. P. Tschan, M. M. Borner, H. J. Altermatt et al., Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression, Oncogene, vol.17, pp.2779-2785, 1998.

K. Haglund, N. Shimokawa, I. Szymkiewicz, and I. Dikic, Cbl-directed monoubiquitination of CIN85 is involved in regulation of ligand-induced degradation of EGF receptors, Proc. Natl. Acad. Sci. USA, vol.99, pp.12191-12196, 2002.